Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.1470
+0.0200 (15.75%)
At close: Sep 26, 2025, 4:00 PM EDT
0.1547
+0.0077 (5.24%)
After-hours: Sep 26, 2025, 4:37 PM EDT
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 506 employees as of December 31, 2024. The number of employees increased by 57 or 12.69% compared to the previous year.
Employees
506
Change (1Y)
57
Growth (1Y)
12.69%
Revenue / Employee
$128,626
Profits / Employee
-$335,486
Market Cap
38.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 506 | 57 | 12.69% |
| Dec 31, 2023 | 449 | -85 | -15.92% |
| Dec 31, 2022 | 534 | 40 | 8.10% |
| Dec 31, 2021 | 494 | 32 | 6.93% |
| Dec 31, 2020 | 462 | 62 | 15.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ADAP News
- 6 weeks ago - Adaptimmune Reports Q2 Financial Results and Provides Business Update - Newsfile Corp
- 2 months ago - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds - Newsfile Corp
- 4 months ago - Adaptimmune Therapeutics plc (ADAP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Adaptimmune Reports Q1 Financial Results and Provides Business Update - Newsfile Corp
- 5 months ago - Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025 - Newsfile Corp
- 6 months ago - Adaptimmune Therapeutics plc (ADAP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Adaptimmune Provides Q4 and Full Year 2024 Business Update - Newsfile Corp
- 7 months ago - Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025 - Newsfile Corp